| Product Code: ETC7382354 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of tetanus toxoid vaccine to Grenada in 2024 saw a significant increase in diversity, with top exporting countries including Barbados, India, Panama, South Korea, and Belgium. The market concentration, as measured by the HHI index, decreased from high to moderate in 2024, indicating a more balanced market share among exporters. The compound annual growth rate (CAGR) from 2020 to 2024 stood at an impressive 24.01%, with a notable growth rate of 67.54% from 2023 to 2024, reflecting a dynamic and expanding market for tetanus toxoid vaccines in Grenada.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Tetanus Toxoid Vaccine Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Tetanus Toxoid Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Tetanus Toxoid Vaccine Market - Industry Life Cycle |
3.4 Grenada Tetanus Toxoid Vaccine Market - Porter's Five Forces |
3.5 Grenada Tetanus Toxoid Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Grenada Tetanus Toxoid Vaccine Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Grenada Tetanus Toxoid Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Grenada Tetanus Toxoid Vaccine Market Trends |
6 Grenada Tetanus Toxoid Vaccine Market, By Types |
6.1 Grenada Tetanus Toxoid Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Grenada Tetanus Toxoid Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Grenada Tetanus Toxoid Vaccine Market Revenues & Volume, By Monovalent Tetanus Toxoid (TT), 2021- 2031F |
6.1.4 Grenada Tetanus Toxoid Vaccine Market Revenues & Volume, By Diphtheria, 2021- 2031F |
6.1.5 Grenada Tetanus Toxoid Vaccine Market Revenues & Volume, By Tetanus, 2021- 2031F |
6.1.6 Grenada Tetanus Toxoid Vaccine Market Revenues & Volume, By Pertussis (DTaP), 2021- 2031F |
6.1.7 Grenada Tetanus Toxoid Vaccine Market Revenues & Volume, By Diphtheria and Tetanus (DT), 2021- 2031F |
6.2 Grenada Tetanus Toxoid Vaccine Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Grenada Tetanus Toxoid Vaccine Market Revenues & Volume, By Hospitals And Clinics, 2021- 2031F |
6.2.3 Grenada Tetanus Toxoid Vaccine Market Revenues & Volume, By Government Organizations, 2021- 2031F |
6.2.4 Grenada Tetanus Toxoid Vaccine Market Revenues & Volume, By Research, 2021- 2031F |
6.2.5 Grenada Tetanus Toxoid Vaccine Market Revenues & Volume, By Others, 2021- 2031F |
7 Grenada Tetanus Toxoid Vaccine Market Import-Export Trade Statistics |
7.1 Grenada Tetanus Toxoid Vaccine Market Export to Major Countries |
7.2 Grenada Tetanus Toxoid Vaccine Market Imports from Major Countries |
8 Grenada Tetanus Toxoid Vaccine Market Key Performance Indicators |
9 Grenada Tetanus Toxoid Vaccine Market - Opportunity Assessment |
9.1 Grenada Tetanus Toxoid Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Grenada Tetanus Toxoid Vaccine Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Grenada Tetanus Toxoid Vaccine Market - Competitive Landscape |
10.1 Grenada Tetanus Toxoid Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Grenada Tetanus Toxoid Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |